List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Humans |
| 4 | Parkinson Disease (drug therapy) |
| 3 | Aged |
| 3 | Antiparkinson Agents (adverse effects) |
| 3 | Antiparkinson Agents (therapeutic use) |
| 3 | Confidence Intervals |
| 3 | Double-Blind Method |
| 3 | Female |
| 3 | Longitudinal Studies |
| 3 | Male |
| 3 | Middle Aged |
| 3 | Ropinirole |
| 3 | Severity of Illness Index |
| 2 | Adult |
| 2 | Analysis of Variance |
| 2 | Disease Progression |
| 2 | Dopamine Agonists (therapeutic use) |
| 2 | Dopamine agonist |
| 2 | Double‐blind, controlled study |
| 2 | Drug Therapy, Combination |
| 2 | Early Parkinson's disease |
| 2 | Indoles (adverse effects) |
| 2 | Indoles (therapeutic use) |
| 2 | Levodopa |
| 2 | Levodopa (adverse effects) |
| 2 | Nervous system diseases |
| 2 | Odds Ratio |
| 2 | Parkinson disease |
| 2 | Parkinson's disease |
| 2 | Regression Analysis |
| 2 | Treatment Outcome |
| 1 | Bromocriptine |
| 1 | Bromocriptine (adverse effects) |
| 1 | Bromocriptine (therapeutic use) |
| 1 | Catechols (therapeutic use) |
| 1 | Dopamine Agonists (adverse effects) |
| 1 | Dyskinesia |
| 1 | Dyskinesia, Drug-Induced (etiology) |
| 1 | Dyskinesia, Drug-Induced (mortality) |
| 1 | Freezing |
| 1 | Freezing Reaction, Cataleptic (drug effects) |
| 1 | Freezing Reaction, Cataleptic (physiology) |
| 1 | Gait Disorders, Neurologic (chemically induced) |
| 1 | Gait Disorders, Neurologic (diagnosis) |
| 1 | Gait Disorders, Neurologic (drug therapy) |
| 1 | Gait Disorders, Neurologic (physiopathology) |
| 1 | Human |
| 1 | Indans (therapeutic use) |
| 1 | Levodopa (therapeutic use) |
| 1 | Neuroprotective Agents (therapeutic use) |
| 1 | Nitriles (therapeutic use) |
| 1 | Parkinson Disease (epidemiology) |
| 1 | Parkinson Disease (mortality) |
| 1 | Predictive Value of Tests |
| 1 | Principal Component Analysis |
| 1 | Proportional Hazards Models |
| 1 | Psychiatric Status Rating Scales |
| 1 | Questionnaire |
| 1 | Questionnaires |
| 1 | Rasagiline |
| 1 | Reproducibility of Results |
| 1 | Risk Factors |
| 1 | Selegiline |
| 1 | Selegiline (therapeutic use) |
| 1 | Statistics as Topic |
| 1 | Survival Analysis |
| 1 | Validation |
| 1 | dyskinesia |
| 1 | freezing of gait |
| 1 | levodopa |
| 1 | rasagiline |
| 1 | ropinirole |
| 1 | validation |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "David J. Brooks"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "David J. Brooks" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= David J. Brooks
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
